Long term safety of infliximab
TF Schaible - Canadian Journal of Gastroenterology and Hepatology - hindawi.com
Infliximab is a chimeric anti-tumour necrosis factor-alpha monoclonal antibody that has been
studied for the treatment of Crohn's disease and rheumatoid arthritis. In several placebo …
studied for the treatment of Crohn's disease and rheumatoid arthritis. In several placebo …
[PDF][PDF] Long term safety of infliximab
TF Schaible - Can J Gastroenterol, 2000 - pdfs.semanticscholar.org
TF Schaible. Long term safety of infliximab. Can J Gastroenterol 2000; 14 (Suppl C): 29C-
32C. Infliximab is a chimeric anti-tumour necrosis factor-alpha monoclonal antibody that has …
32C. Infliximab is a chimeric anti-tumour necrosis factor-alpha monoclonal antibody that has …
Long term safety of infliximab.
TF Schaible - … Journal of Gastroenterology= Journal Canadien de …, 2000 - europepmc.org
Infliximab is a chimeric anti-tumour necrosis factor-alpha monoclonal antibody that has been
studied for the treatment of Crohn's disease and rheumatoid arthritis. In several placebo …
studied for the treatment of Crohn's disease and rheumatoid arthritis. In several placebo …
Long term safety of infliximab
TF Schaible - Canadian journal of gastroenterology …, 2000 - pubmed.ncbi.nlm.nih.gov
Infliximab is a chimeric anti-tumour necrosis factor-alpha monoclonal antibody that has been
studied for the treatment of Crohn's disease and rheumatoid arthritis. In several placebo …
studied for the treatment of Crohn's disease and rheumatoid arthritis. In several placebo …